Quantitative prediction of pharmacokinetic properties of drugs in humans: Recent advance in in vitro models to predict the impact of efflux transporters in the small intestine and blood–brain barrier
Efflux transport systems are essential to suppress the absorption of xenobiotics from the intestinal lumen and protect the critical tissues at the blood-tissue barriers, such as the blood–brain barrier. The function of drug efflux transport is dominated by various transporters. Accumulated clinical...
Enregistré dans:
Auteurs principaux: | Yoshiki Hashimoto, Kazuyoshi Michiba, Kazuya Maeda, Hiroyuki Kusuhara |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2022
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/52b58402967f4b5ea619d61a35dd957e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Mechanisms and the clinical relevance of complex drug–drug interactions
par: Roberts AG, et autres
Publié: (2018) -
Identified Seaweed Compound Diphenylmethane Serves as an Efflux Pump Inhibitor in Drug-Resistant <i>Escherichia coli</i>
par: Wen-Jung Lu, et autres
Publié: (2021) -
A pharmacokinetics‐based approach to the monitoring of patient adherence to atorvastatin therapy
par: Gellért Balázs Karvaly, et autres
Publié: (2021) -
Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump
par: Elizabeth M. Grimsey, et autres
Publié: (2020) -
The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development
par: Cvijić Sandra, et autres
Publié: (2021)